Aminoglycoside Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NKTR | A | Nektar Therapeutics | -4.07 | |
MTNB | F | Matinas Biopharma Holdings, Inc. | 0.37 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BIS | A | ProShares UltraShort Nasdaq Biotechnology | 0.48 | |
PRFZ | B | PowerShares FTSE RAFI US 1500 Small-Mid Portfolio | 0.04 | |
SCHA | C | Schwab U.S. Small-Cap ETF | 0.01 | |
SCHB | B | Schwab U.S. Broad Market ETF | 0.0 | |
VXF | B | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
- Aminoglycoside
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar). The term can also refer more generally to any organic molecule that contains amino sugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria.Streptomycin is the first-in-class aminoglycoside antibiotic. It is derived from Streptomyces griseus and is the earliest modern agent used against tuberculosis. Streptomycin lacks the common 2-deoxystreptamine moiety (image right, below) present in most other members of this class. Other examples of aminoglycosides include the deoxystreptamine-containing agents kanamycin, tobramycin, gentamicin, and neomycin (see below).
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles